These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28677621)

  • 1. Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis.
    Gębura K; Świerkot J; Wysoczańska B; Korman L; Nowak B; Wiland P; Bogunia-Kubik K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia.
    Rybka J; Gębura K; Wróbel T; Wysoczańska B; Stefanko E; Kuliczkowski K; Bogunia-Kubik K
    Int J Immunogenet; 2016 Apr; 43(2):101-6. PubMed ID: 26919710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models.
    Kim W; Kim TH; Oh SJ; Kim HJ; Kim JH; Kim HA; Jung JY; Choi IA; Lee KE
    Sci Rep; 2021 Oct; 11(1):20169. PubMed ID: 34635730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment.
    Marwa OS; Kalthoum T; Wajih K; Kamel H
    Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NHH; Andersen V
    Pharmacogenomics J; 2018 Jan; 18(1):81-86. PubMed ID: 27698401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of genetic polymorphisms within nuclear factor-κB signaling pathway genes in rheumatoid arthritis: Evidence for replication and genetic interaction.
    Zeng Z; Sun QQ; Zhang W; Wen QW; Wang TH; Qin W; Xiao DM; Zhang Z; Huang H; Mo YJ; Wu XD; Cen H
    Int Immunopharmacol; 2021 Nov; 100():108089. PubMed ID: 34464884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis.
    Bogunia-Kubik K; Świerkot J; Malak A; Wysoczańska B; Nowak B; Białowąs K; Gębura K; Korman L; Wiland P
    Arch Immunol Ther Exp (Warsz); 2015 Jun; 63(3):215-21. PubMed ID: 25387578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis.
    Bogunia-Kubik K; Wysoczańska B; Piątek D; Iwaszko M; Ciechomska M; Świerkot J
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):131-136. PubMed ID: 28083614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.
    Ceccarelli F; D'Alfonso S; Perricone C; Carlomagno Y; Alessandri C; Croia C; Barizzone N; Montecucco C; Galeazzi M; Sebastiani GD; Minisola G; Fiocco U; Valesini G
    Clin Exp Rheumatol; 2012; 30(6):939-42. PubMed ID: 22992305
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Iwaszko M; Wielińska J; Świerkot J; Kolossa K; Sokolik R; Bugaj B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
    Front Immunol; 2021; 12():631603. PubMed ID: 34177886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.
    Iwaszko M; Świerkot J; Kolossa K; Jeka S; Wiland P; Bogunia-Kubik K
    Joint Bone Spine; 2016 Jan; 83(1):75-9. PubMed ID: 26453102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
    Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AH; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedrén S; Ding B; Guiducci C; Wolbink GJ; Crusius JB; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TW; Tak PP; Bridges SL; Toes RE; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
    Arthritis Rheum; 2010 Jul; 62(7):1849-61. PubMed ID: 20309874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome.
    Coenen MJ; Enevold C; Barrera P; Schijvenaars MM; Toonen EJ; Scheffer H; Padyukov L; Kastbom A; Klareskog L; Barton A; Kievit W; Rood MJ; Jansen TL; Swinkels D; van Riel PL; Franke B; Bendtzen K; Radstake TR
    PLoS One; 2010 Dec; 5(12):e14326. PubMed ID: 21179534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.
    Swierkot J; Bogunia-Kubik K; Nowak B; Bialowas K; Korman L; Gebura K; Kolossa K; Jeka S; Wiland P
    Joint Bone Spine; 2015 Mar; 82(2):94-9. PubMed ID: 25311255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
    Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
    Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment.
    Mathews RJ; Robinson JI; Battellino M; Wong C; Taylor JC; ; Eyre S; Churchman SM; Wilson AG; Isaacs JD; Hyrich K; Barton A; Plant D; Savic S; Cook GP; Sarzi-Puttini P; Emery P; Barrett JH; Morgan AW; McDermott MF
    Ann Rheum Dis; 2014 Jun; 73(6):1202-10. PubMed ID: 23687262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.
    Cadena-Sandoval D; Alemán-Ávila I; Barbosa-Cobos RE; Becerril-Mendoza LT; Fragoso JM; Ramírez-Bello J
    Mol Biol Rep; 2018 Jun; 45(3):227-232. PubMed ID: 29404828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.